Compare GRANULES INDIA with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA DR. REDDYS LAB GRANULES INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 16.0 28.5 56.2% View Chart
P/BV x 3.1 4.2 73.6% View Chart
Dividend Yield % 0.6 0.6 98.9%  

Financials

 GRANULES INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
DR. REDDYS LAB
Mar-21
GRANULES INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4385,515 7.9%   
Low Rs1383,028 4.6%   
Sales per share (Unadj.) Rs130.71,145.4 11.4%  
Earnings per share (Unadj.) Rs22.2114.5 19.4%  
Cash flow per share (Unadj.) Rs28.3188.4 15.0%  
Dividends per share (Unadj.) Rs1.5025.00 6.0%  
Avg Dividend yield %0.50.6 89.0%  
Book value per share (Unadj.) Rs86.81,053.2 8.2%  
Shares outstanding (eoy) m247.67166.30 148.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.23.7 59.1%   
Avg P/E ratio x13.037.3 34.8%  
P/CF ratio (eoy) x10.222.7 44.9%  
Price / Book Value ratio x3.34.1 81.8%  
Dividend payout %6.821.8 31.0%   
Avg Mkt Cap Rs m71,337710,289 10.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24336,299 8.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,375190,475 17.0%  
Other income Rs m2692,914 9.2%   
Total revenues Rs m32,644193,389 16.9%   
Gross profit Rs m8,55238,699 22.1%  
Depreciation Rs m1,51512,288 12.3%   
Interest Rs m263970 27.1%   
Profit before tax Rs m7,04428,355 24.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5499,319 16.6%   
Profit after tax Rs m5,49519,036 28.9%  
Gross profit margin %26.420.3 130.0%  
Effective tax rate %22.032.9 66.9%   
Net profit margin %17.010.0 169.8%  
BALANCE SHEET DATA
Current assets Rs m19,970145,503 13.7%   
Current liabilities Rs m11,73181,038 14.5%   
Net working cap to sales %25.433.8 75.2%  
Current ratio x1.71.8 94.8%  
Inventory Days Days1661 26.6%  
Debtors Days Days86395 907.2%  
Net fixed assets Rs m17,157109,979 15.6%   
Share capital Rs m248832 29.8%   
"Free" reserves Rs m21,262174,319 12.2%   
Net worth Rs m21,510175,151 12.3%   
Long term debt Rs m3,4116,299 54.2%   
Total assets Rs m37,127255,482 14.5%  
Interest coverage x27.830.2 91.9%   
Debt to equity ratio x0.20 441.0%  
Sales to assets ratio x0.90.7 117.0%   
Return on assets %15.57.8 198.0%  
Return on equity %25.510.9 235.0%  
Return on capital %29.316.2 181.4%  
Exports to sales %81.951.3 159.7%   
Imports to sales %26.818.1 148.5%   
Exports (fob) Rs m26,52897,699 27.2%   
Imports (cif) Rs m8,69134,420 25.2%   
Fx inflow Rs m26,52897,699 27.2%   
Fx outflow Rs m8,69134,420 25.2%   
Net fx Rs m17,83763,279 28.2%   
CASH FLOW
From Operations Rs m4,32535,703 12.1%  
From Investments Rs m-2,771-22,660 12.2%  
From Financial Activity Rs m-2,993-298 1,004.4%  
Net Cashflow Rs m-1,44112,858 -11.2%  

Share Holding

Indian Promoters % 41.6 26.7 155.8%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 27.2 49.9 54.4%  
FIIs % 23.2 25.2 92.2%  
ADR/GDR % 0.0 11.2 -  
Free float % 58.0 62.1 93.5%  
Shareholders   210,785 263,803 79.9%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   CIPLA    SUN PHARMA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


May 27, 2022 03:30 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA - AUROBINDO PHARMA COMPARISON

COMPARE GRANULES INDIA WITH

MARKET STATS